Critical Consideration of Myxedema Coma in the Postoperative Setting: A Case Report

A&A Practice
Minh TranAngela Meier

Abstract

Myxedema coma is a rare but highly fatal condition with reported mortality >40%-50%. Early recognition and prompt treatment are critical for survival. Here we describe a case of possible postoperative myxedema coma after subacute neck hematoma evacuation after hemithyroidectomy in a patient on concurrent amiodarone therapy. Symptoms included somnolence, hypothermia, and prolonged QTc with torsades de pointes resistant to magnesium therapy requiring defibrillation and overdrive pacing. Consideration of the possible diagnosis of myxedema coma resulted in prompt therapy and symptom resolution within 48 hours. Thyroid disorders, although rare, should be considered in the postoperative setting.

References

Dec 15, 1992·Annals of Internal Medicine·S D MacKerrowP Economou
Jun 1, 1990·The American Journal of Medicine·I Klein
Jan 1, 1985·Acta Endocrinologica·B Hylander, U Rosenqvist
Jan 1, 1964·Archives of Internal Medicine·D N HOLVEYJ T DOWLING
Aug 23, 2007·Journal of Intensive Care Medicine·Maxwell P Kwaku, Kenneth D Burman
Jul 9, 2010·The Annals of Thoracic Surgery·Yong YuanYongfan Zhao
Mar 27, 2012·The Medical Clinics of North America·Joanna Klubo-Gwiezdzinska, Leonard Wartofsky
Jan 1, 2014·Respiratory Medicine Case Reports·Rapeephan R Maude, Michael Barretti

❮ Previous
Next ❯

Citations

May 4, 2021·Current Opinion in Anaesthesiology·Claudia Fernandez-RoblesAdriana D Oprea

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.